4.7 Article

RadSigBench: a framework for benchmarking functional genomics signatures of cancer cell radiosensitivity

期刊

BRIEFINGS IN BIOINFORMATICS
卷 23, 期 2, 页码 -

出版社

OXFORD UNIV PRESS
DOI: 10.1093/bib/bbab561

关键词

prediction modelling; cancer; transcriptomics; radiation therapy; radiosensitivity

资金

  1. UKRI Future Leaders Fellowship [MR/T021721/1]

向作者/读者索取更多资源

This study presents a comprehensive benchmarking framework for radio sensitivity (RS) signatures, evaluating multiple published signatures and comparing them to control signatures. The results show that both published and cellular process signatures have limited radiation-specific information. Therefore, improved modeling strategies are needed to predict intrinsic RS accurately.
Multiple transcriptomic predictors of tumour cell radiosensitivity (RS) have been proposed, but they have not been benchmarked against one another or to control models. To address this, we present RadSigBench, a comprehensive benchmarking framework for RS signatures. The approach compares candidate models to those developed from randomly resampled control signatures and from cellular processes integral to the radiation response. Robust evaluation of signature accuracy, both overall and for individual tissues, is performed. The NCI60 and Cancer Cell Line Encyclopaedia datasets are integrated into our workflow. Prediction of two measures of RS is assessed: survival fraction after 2 Gy and mean inactivation dose. We apply the RadSigBench framework to seven prominent published signatures of radiation sensitivity and test for equivalence to control signatures. The mean out-of-sample R-2 for the published models on test data was very poor at 0.01 (range: -0.05 to 0.09) for Cancer Cell Line Encyclopedia and 0.00 (range: -0.19 to 0.19) in the NCI60 data. The accuracy of both published and cellular process signatures investigated was equivalent to the resampled controls, suggesting that these signatures contain limited radiation-specific information. Enhanced modelling strategies are needed for effective prediction of intrinsic RS to inform clinical treatment regimes. We make recommendations for methodological improvements, for example the inclusion of perturbation data, multiomics, advanced machine learning and mechanistic modelling. Our validation framework provides for robust performance assessment of ongoing developments in intrinsic RS prediction.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据